Quotes Protalix BioTherapeutics, Inc. TEL AVIV STOCK EXCHANGE
Stocks
PLX
US74365A3095
Pharmaceuticals
|
Delayed
TEL AVIV STOCK EXCHANGE
11:24:48 2023-03-21 EDT
|
5-day change | 1st Jan Change | ||
| 732.50 ILa | -.--% |
|
+3.29% | +69.68% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (ILa)
0
Market Cap (USD)
-
Net sales (USD)
52,744,000
Indicators
Moving average 5 days
739.28
Moving average 20 days
687.88
Moving average 50 days
601.04
Moving average 100 days
500.5
RSI 9 days
58.89
RSI 14 days
60.83
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | |
| +4.46% | +4.92% | +82.07% | +134.31% | 1,093B | |
| +0.85% | +4.81% | +53.77% | +58.51% | 653B | |
| +2.72% | +6.92% | +28.99% | +77.15% | 458B | |
| +1.80% | +0.52% | +41.20% | +44.05% | 355B | |
| +1.24% | +2.35% | +25.99% | +42.21% | 294B | |
| +2.07% | +2.97% | +2.27% | +13.06% | 248B | |
| +4.02% | +6.29% | +49.67% | +68.96% | 230B | |
| +1.05% | -0.02% | -13.96% | -52.13% | 203B | |
| +2.90% | +8.63% | +25.11% | +94.52% | 178B | |
| Average | +1.73% | +3.13% | +32.79% | +53.40% | 371.07B | |
| Weighted average by Cap. | +1.53% | +3.65% | +46.87% | +73.74% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- PLX Stock
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
